pI: 5.1597 |
Length (AA): 252 |
MW (Da): 27511 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 250 | 3u1k (A) | 346 | 616 | 18.00 | 0.00000000012 | 1 | 1.1204 | 0.08 |
6 | 241 | 2po1 (A) | 9 | 241 | 29.00 | 0 | 1 | 1.36691 | -0.68 |
6 | 177 | 2wp8 (B) | 5 | 178 | 36.00 | 0 | 1 | 0.97524 | 0.31 |
6 | 239 | 2br2 (B) | 11 | 242 | 24.00 | 0 | 1 | 1.33387 | -0.75 |
8 | 239 | 2nn6 (B) | 6 | 236 | 29.00 | 0 | 1 | 1.28903 | -0.06 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127234)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G61620 | exonuclease RRP41 |
Babesia bovis | BBOV_IV005940 | exosome complex exonuclease rrp41, putative |
Brugia malayi | Bm1_33890 | Putative exosome complex exonuclease RRP41 |
Candida albicans | CaO19.12051 | likely 3' exoribonuclease similar to S. cerevisiae SKI6 (YGR195W)exosome component involved mRNA degradation and nuclear RNA pro |
Candida albicans | CaO19.4582 | likely 3' exoribonuclease similar to S. cerevisiae SKI6 (YGR195W)exosome component involved mRNA degradation and nuclear RNA pro |
Caenorhabditis elegans | exos-4.1 | Protein EXOS-4.1, isoform A |
Cryptosporidium hominis | Chro.40450 | exosome complex exonuclease RRP41 |
Cryptosporidium parvum | cgd4_3930 | archeo-eukaryotic exosomal RNAse |
Dictyostelium discoideum | DDB_G0291328 | hypothetical protein |
Drosophila melanogaster | Dmel_CG15481 | CG15481 gene product from transcript CG15481-RB |
Echinococcus granulosus | EgrG_000458000 | exosome complex component RRP41 |
Entamoeba histolytica | EHI_040320 | 3 exoribonuclease family protein |
Echinococcus multilocularis | EmuJ_000458000 | exosome complex component RRP41 |
Homo sapiens | ENSG00000178896 | exosome component 4 |
Leishmania braziliensis | LbrM.35.3240 | exosome complex exonuclease rrp41, putative |
Leishmania donovani | LdBPK_363170.1 | Ribosomal RNA processing protein 41A |
Leishmania infantum | LinJ.36.3170 | exosome complex exonuclease rrp41, putative |
Leishmania major | LmjF.36.3020 | exosome complex exonuclease rrp41, putative |
Leishmania mexicana | LmxM.36.3020 | exosome complex exonuclease rrp41, putative |
Loa Loa (eye worm) | LOAG_00358 | EXOSome component family member |
Mycobacterium leprae | ML1174 | PROBABLE RIBONUCLEASE RPHA (RNase PH) (tRNA nucleotidyltransferase) |
Mus musculus | ENSMUSG00000034259 | exosome component 4 |
Mycobacterium tuberculosis | Rv1340 | Probable ribonuclease RphA (RNase PH) (tRNA nucleotidyltransferase) |
Mycobacterium ulcerans | MUL_3908 | ribonuclease PH |
Neospora caninum | NCLIV_031410 | hypothetical protein |
Oryza sativa | 4346519 | Os09g0252000 |
Onchocerca volvulus | OVOC2627 | Mitochondrial import inner membrane translocase subunit Tim10B homolog |
Plasmodium berghei | PBANKA_1016800 | exosome complex exonuclease RRP41, putative |
Plasmodium falciparum | PF3D7_1427800 | exosome complex exonuclease RRP41, putative |
Plasmodium knowlesi | PKNH_1330900 | exosome complex exonuclease RRP41, putative |
Plasmodium vivax | PVX_085150 | exosome complex exonuclease RRP41, putative |
Plasmodium yoelii | PY07159 | exonuclease RRP41, putative |
Saccharomyces cerevisiae | YGR195W | Ski6p |
Schistosoma japonicum | Sjp_0304560 | ko:K01149 Ski6 [EC:3.1.13.-], putative |
Schistosoma mansoni | Smp_012110 | ribonuclease pH related |
Schmidtea mediterranea | mk4.009255.04 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.000566.05 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.000940.04 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.023580.00 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.014029.02 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.034062.01 | |
Schmidtea mediterranea | mk4.006882.02 | Exosome complex component RRP41 |
Schmidtea mediterranea | mk4.008988.01 | Exosome complex component RRP41 |
Trypanosoma brucei gambiense | Tbg972.10.9130 | exosome complex exonuclease RRP41A,RRP41p homologue, putative |
Trypanosoma brucei | Tb927.10.7450 | Ribosomal RNA processing protein 41A |
Trypanosoma congolense | TcIL3000_10_6420 | Ribosomal RNA processing protein 41A |
Trypanosoma cruzi | TcCLB.509715.9 | Ribosomal RNA processing protein 41A |
Trypanosoma cruzi | TcCLB.510105.20 | exosome complex exonuclease RRP41A |
Theileria parva | TP01_0398 | exosome complex exonuclease rrp41, putative |
Trichomonas vaginalis | TVAG_250040 | Exosome complex exonuclease RRP41, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7450 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7450 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7450 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.7450 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YGR195W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1016800 | Plasmodium berghei | Slow | plasmo |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tbru020513; Recombinant protein: full-length; Source: T brucei; RRP41p homologue ; |
1 literature reference was collected for this gene.